Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-03-09 4:17 pm Purchase |
2023-03-01 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Carlyle Group Inc. CG |
2,935,106 6.700% |
2,935,106![]() (New Position) |
Filing History |
2023-02-14 1:58 pm Purchase |
2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Avidity Partners Management LP | 1,900,000 4.600% |
4,000![]() (+0.21%) |
Filing History |
2023-02-10 3:59 pm Sale |
2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Deerfield Mgmt, L.P. | 0 0.000% |
-2,414,897![]() (Position Closed) |
Filing History |
2023-02-09 11:30 am Sale |
2022-12-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
The Vanguard Group | 1,076,605 2.590% |
-851,239![]() (-44.15%) |
Filing History |
2023-02-09 11:18 am Sale |
2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
JANUS HENDERSON GROUP PLC JHG |
2,952 0.000% |
-1,838,405![]() (-99.84%) |
Filing History |
2023-02-02 3:08 pm Purchase |
2023-02-02 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Invesco Ltd. IVZ |
2,207,649 5.300% |
140,293![]() (+6.79%) |
Filing History |
2023-01-31 4:00 pm Purchase |
2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Medicxi Growth I LP | 2,484,274 6.000% |
416,413![]() (+20.14%) |
Filing History |
2022-09-26 4:00 pm Purchase |
2022-09-22 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 8,424,772 21.500% |
203,448![]() (+2.47%) |
Filing History |
2022-09-23 5:15 pm Purchase |
2022-09-22 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Deerfield Mgmt, L.P. | 2,414,897 5.810% |
2,414,897![]() (New Position) |
Filing History |
2022-08-11 3:55 pm Purchase |
2022-08-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 8,221,324 21.000% |
2,377,400![]() (+40.68%) |
Filing History |
2022-05-16 4:32 pm Sale |
2022-05-16 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
RA CAPITAL MANAGEMENT L.P. | 0 0.000% |
-3,115,008![]() (Position Closed) |
Filing History |
2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
RA CAPITAL MANAGEMENT L.P. | 3,115,008 9.900% |
-710,000![]() (-18.56%) |
Filing History |
2022-02-11 6:16 pm Purchase |
2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Avidity Partners Management LP | 1,896,000 6.000% |
1,896,000![]() (New Position) |
Filing History |
2022-02-10 4:54 pm Sale |
2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
JANUS HENDERSON GROUP PLC JHG |
1,841,357 5.900% |
-97,079![]() (-5.01%) |
Filing History |
2022-02-10 4:16 pm Sale |
2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Yamada Tadataka | 0 0.000% |
-1,687,721![]() (Position Closed) |
Filing History |
2022-02-10 11:32 am Purchase |
2022-02-09 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Invesco Ltd. IVZ |
2,067,356 6.600% |
12,918![]() (+0.63%) |
Filing History |
2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
The Vanguard Group | 1,927,844 6.140% |
1,927,844![]() (New Position) |
Filing History |
2021-11-12 06:03 am Sale |
2021-11-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 7,459,304 19.200% |
-1,212,696![]() (-13.98%) |
Filing History |
2021-04-06 06:05 am Unchanged |
2021-04-02 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 8,672,000 22.300% |
0 (Unchanged) |
Filing History |
2021-04-01 06:06 am Unchanged |
2021-03-31 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 8,672,000 22.300% |
0 (Unchanged) |
Filing History |